Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 5Fatigue 5Breast Neoplasms 5Anxiety Disorders 3Lung Neoplasms 2Uterine Neoplasms 1Substance-Related Disorders 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Psychological Well-Being 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasm Regression, Spontaneous 1Multiple Myeloma 1Lymphoma 1Leukemia 1Glioblastoma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Cognitive Dysfunction 1Chronic Pain 1Caregiver Burden 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Oxaliplatin 14Fluorouracil 11Capecitabine 9Surveys and Questionnaires 8Leucovorin 8Irinotecan 8Cisplatin 8Bevacizumab 8Standard of Care 5Gemcitabine 5Drug Therapy 4S 1 (combination) 3Radiotherapy 3Nivolumab 3Interviews as Topic 3IFL protocol 3Educational Status 3Cyclophosphamide 3Colonoscopy 3Blood Specimen Collection 35,10-methylenetetrahydrofolic acid 3trebananib 2tivozanib 2pembrolizumab 2Taxes 2Remote Patient Monitoring 2Pemetrexed 2Panitumumab 2Ocoxin 2N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Neoplasms × Acceptance and Commitment Therapy × Clear all
NCT04010227 2022-12-22

Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers

Indiana University

Phase NA Completed
84 enrolled 30 charts
Gastrointestinal

Fatigue, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡